Skip to content ↓

Topic

Research

Download RSS feed: News Articles / In the Media / Audio

Displaying 4156 - 4170 of 5696 news clips related to this topic.
Show:

The New Yorker

In an article for The New Yorker, Nathan Heller highlights research specialist Kate Darling’s work examining how humans interact with robots. Darlings’ research suggests that “our aversion to abusing lifelike machines comes from “‘societal values.’”

The Washington Post

Prof. Fotini Christia and grad students Elizabeth Dekeyser and Dean Knox write for The Washington Post about how they surveyed religious Shiites from Iran and Iraq concerning their views on religion, politics and more. The authors write that the survey, which was conducted during an annual pilgrimage, “presents a unique template for surveying hard-to-reach populations in an increasingly mobile world.”

Economist

MIT researchers have devised a capsule that can deliver medications over extended periods of time, and could be useful in halting the spread of malaria. The Economist notes that the device could be a “useful addition to the armory being deployed against malaria. And that, alone, could save many lives a year.”

WCVB

In this WCVB segment, CSAIL postdocs Robert MacCurdy and Jeffrey Lipton explain their work developing a shock-absorbing material that could be used to help protect robots and smartphones, or in helmets. Liquid is used in the material to “absorb the energy and keep it inside,” Lipton explains.

STAT

Bob Tedeschi writes for STAT that MIT researchers have developed a device that can remain in the stomach for up to two weeks, gradually releasing medication. “The capsule represents the latest effort to solve a major flaw in drug delivery,” Tedeschi explains. “Because the human stomach clears its contents multiple times daily, pill takers must dose themselves frequently.”

Popular Science

MIT researchers have developed a new drug delivery capsule that can deliver medication over extended periods of time, reports Claire Maldarelli for Popular Science. Once in the stomach, the capsule opens into a star shape, which “prevents the pill from leaving the stomach and entering the small intestine.”

The Atlantic

In a series of papers, the New Horizons team, which includes MIT researchers, reveals that there may be a slushy subsurface ocean on Pluto, reports Rebecca Boyle for The Atlantic. “The research suggests that many other distant worlds in the Kuiper Belt might also hold inner oceans of water, or other liquids,” Boyle explains.

Boston Magazine

Researchers at MIT have developed a slow-release drug capsule that can last two weeks in a person’s stomach, writes Jamie Ducharme for Boston Magazine. “The capsule was tested for use in malaria prevention, but the researchers behind it say it could be used for virtually any condition that requires regular oral medication,” Ducharme explains.

Reuters

Researchers involved with the NASA New Horizons mission have uncovered evidence that an ocean of ice water lies beneath Pluto’s heart-shaped basin, reports Irene Klotz for Reuters. Prof. Richard Binzel explains that the findings show that “nature is more creative than we are able to imagine, which is why we go and explore."

Reuters

Reuters reporter Kate Kelland writes that MIT researchers have created a new drug-delivery capsule that can stay in the stomach for up to two weeks after being swallowed. The star-shaped device could be “a powerful weapon in fighting malaria, HIV and other diseases where successful treatment depends on repeated doses of medicine.”

Boston Globe

Boston Globe reporter Olivia Quintana writes that the NASA New Horizons team, which includes MIT researchers, has collected data that suggests there is a slushy ocean of ice water beneath Pluto’s surface. “I think the big picture is that this is telling us that Pluto is much more complicated, much more fascinating than we ever imagined,” explains Prof. Richard Binzel. 

Los Angeles Times

MIT researchers have developed a star-shaped, drug-delivery device that can stay in the stomach for up to two weeks, gradually releasing medication, reports Melissa Healy for The Los Angeles Times. The researchers believe the device could be useful in “delivering a wide range of medications for diseases in which patient non-adherence is a problem.”

New Scientist

Hal Hodson writes for New Scientist that MIT researchers have developed a system that allows virtual reality headsets to operate wirelessly. To solve the problem posed by sending vast amounts of data wirelessly, the researchers used a “different wireless technology called millimeter wave (mmWave), which is in a higher band of the frequency spectrum to that used by Wi-Fi.”

Straits Times

Straits Times reporter Nadia Chevroulet writes that researchers from MIT and the Singapore-MIT Alliance for Research and Technology (SMART) have uncovered how certain bacteria evade the body’s defenses. The findings could provide “new ways to counter tuberculosis, and possibly a new generation of drugs to battle antibiotic resistance.”

Boston Globe

Boston Globe reporter Priyanka Dayal McCluskey writes that researchers from the Broad Institute and IBM are joining forces to examine why many cancer patients become resistant to drugs. The researchers hope this new effort could “help doctors prescribe more effective combinations of drugs for cancer patients.”